Dr Lal Pathlabs stock is in focus for its upcoming bonus and dividend rewards. JM Financial has suggested buy for target price of Rs 3,699.

Investors will closely watch Indias Manufacturing PMI data today and the US JOLTS job openings report tomorrow. Key earnings scheduled for release include State Bank of India, Mahindra & Mahindra, ...

Q3 2025 Management View Richard Paulson, President and CEO, highlighted a "very productive quarter for Karyopharm, one defined by meaningful clinical progress and strengthened financial flexibility ...

Kimberly-Clark is buying Tylenol maker Kenvue for nearly $50 billion, and Wall Street isn’t too fond of the deal. And for ...

Tokenization may be transforming global finance, but bringing venture capital on-chain remains a work in progress.